Hello, Welcome to Shine Consultant !
Summit & Event Shine Speaker Bureau Shine Advisor Shine Event Service
  • Summit & Event :
    With field research of markets and industries which is analyzed from a global strategic perspective by our professional teams, as well as hot topics which interest leadership and management, Shine Consultant provides you with one-stop platform of dialogue, practice -sharing and social network!
  • Shine Speaker Bureau:
    Committed to provide keynote speakers, executive learning masterclasses and boardroom advisory for global enterprises and institutions, each service provides a deeper and more interactive experience, especially for small, selected audiences and key individuals. We have the resources of the most influential business leaders and experts, who are the most outstanding representatives in their fields. Our team consists of experienced speech and event managers, and we focus on building long-term and in-depth partnerships.
  • Shine Advisor:
    As world-class insight network, we connects clients-decision makers with vetted subject matter experts-advisors. Our clients leverage the insights and perspectives shared by our advisors to stay informed and make better business decisions.We have over 600,000 Shine Advisors in 20 industries, which continues to grow every day.
  • Shine Event Service:
    Committed to be the world's most professional provider of industrial Summit & Event. We provide one-stop professional services, including investigating and planning, on-demand inviting, marketing and promoting, operating, project management, live& digital conference, each service is performed by an experienced professional team matched with long-term industrial resources. We focus on establishing long-term and in-depth partnerships.
Guest Information
Yuanwei Chen
Yuanwei Chen
Positions:

CEO

Company:

Hinova Pharmaceuticals Inc.

陈元伟博士,美籍华人,瑞士洛桑大学博士,美国Scripps研究所博士后。国家千人计划特聘专家成都海创药业有限公司创始人和总经理,四川大学特聘教授,四川省千人计划,成都市人才计划特聘专家,2012年度成都市十佳科技创新人才。先后担任美国拜耳(Bayer)制药资深科学家和项目管理人,安全委员会主席;美国雅培(Abbott Lab)制药公司高级科学家;白鹭医药技术(上海)首席科技官和创始科学家。上海睿智化学药物化学副总裁,成都睿智化学总经理等职务。主要研究方向是重大疾病如癌症,糖尿病,心血管疾病创新药物研究和产业化。 陈元伟博士具有22年国内外著名制药公司药物研发和管理经验,在中国和美国共领导和参与了20多种新药项目的研究,其中5种正在进行临床I,Ⅱ期试验,1种(糖尿病新药)在美国进行Ⅲ期临床研究。共申请了一类新药相关的各项专利80项,已经授权30项,发表论文50余篇。其中包括了糖尿病药SGLT2抑制剂的核心专利(US7,838,499; US7,803,778), 治疗流行性感冒核心专利(US6,518,305),癌症新药研究核心专利(US6,849,638)